Krazati withdrawal completed; Wegovy trial meets endpoint for kids ages 6 to 12
Plus news about Structure Therapeutics, Cloverleaf Bio and Windward Bio. FDA finalizes Krazati withdrawal: Regulators officially finalized the drug’s withdrawal in second-line colorectal cancer last week. Krazati had
September 8, 2026 11:21 AM EDT News Briefing Krazati withdrawal completed; Wegovy trial meets endpoint for kids ages 6 to 12 ENDPOINTS Plus news about Structure Therapeutics, Cloverleaf Bio and Windward Bio. FDA finalizes Krazati withdrawal: Regulators officially finalized the drug’s withdrawal … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that